Applications of Sotalol in Industrial Manufacturing

Sotalol, a non-selective beta-adrenergic receptor antagonist with Class III antiarrhythmic properties, serves as a key chemical intermediate and active pharmaceutical ingredient in specialized downstream industries. Our facility supplies Sotalol under strict quality systems designed to meet the precise technical and regulatory demands of advanced manufacturing. Below, we detail the core industrial applications grouped by real-world segments and describe the unique requirements for each use case.

1. Pharmaceutical Manufacturing: Oral Solid Dosage Formulations

Major pharmaceutical firms use Sotalol as an essential ingredient in the production of oral antiarrhythmic medicines (tablets and capsules) indicated for ventricular and atrial arrhythmias. Manufacturers must formulate using strictly regulated quantities to guarantee dose accuracy, safety, and compliance with global health authority guidelines. Granulation, blending, and tablet compression require API with consistent polymorphic profile and well-defined particle size, ensuring predictable dissolution and bioavailability in the final product. Our production lines deliver Sotalol tailored for high-volume solid formulation environments, including direct compression and wet granulation lines.

Industry compliance standards

• USP (United States Pharmacopeia, monograph: Sotalol Hydrochloride)
• Ph. Eur. (European Pharmacopoeia, Sotalol Hydrochloride)
• Japanese Pharmacopoeia (JP)
• cGMP as per ICH Q7A guidelines

Typical usage ratio

• Active percentage in tablet: 80–160 mg Sotalol HCl per unit dose; typical formulation load 10–20% w/w relative to excipients, adjusted based on dosage strength

Downstream process integration

• Sotalol is introduced at the dry blending or pre-granulation step, followed by wet granulation, drying, milling, blending, compression, and film coating as necessary

Final product types

• Oral tablets (uncoated and film-coated)
• Hard gelatin capsules

2. Pharmaceutical Manufacturing: Parenteral Solution Formulations

Injection solution manufacturers incorporate high-purity Sotalol in their parenteral production pipelines for use in acute care settings targeting arrhythmias. In these sterile environments, our material supports the formulation of clear, injectable solutions in strict observance of microbial and particulate standards. Aseptic processing demands precise pH adjustment and solubility control. We supply material with low endotoxin content meeting injectable-grade standards, supporting critical downstream preparation of ampoules and vials for hospital and clinical use.

Industry compliance standards

• USP and Ph. Eur. injectable grade requirements
• US FDA 21 CFR Part 211 (Current Good Manufacturing Practice for Finished Pharmaceuticals)
• EU GMP Annex 1 (Manufacture of Sterile Medicinal Products)
• ISO 14644 for cleanroom particulate control

Typical usage ratio

• Typical concentration: 5 mg/mL Sotalol hydrochloride in buffered saline solution; ratio adjusted based on final container size and intended clinical use

Downstream process integration

• Sotalol is dissolved in water for injection during bulk solution preparation, filtered, pH-adjusted, sterile filtered, filled into primary containers (vials/ampoules), followed by terminal sterilization or aseptic sealing

Final product types

• Single-dose injectable vials
• Multi-dose bulk injection ampoules

3. Contract Development and Manufacturing Organizations (CDMO): Custom API Grades

CDMOs frequently require Sotalol for tailored active ingredient production, especially for clinical trial batches, pediatric formulations, or region-specific releases. Specifications may include distinct salt forms, particle size distribution, or polymorphic requirements. Our synthesis and purification teams collaborate to provide custom batch sizes and documentation needed for investigational new drug (IND) and abbreviated new drug application (ANDA) filings. Material is analyzed for compliance with research-phase standards, including advanced impurity profiling and stability testing, to support fast-track development timelines.

Industry compliance standards

• Research-use only (RUO) grade as per specific sponsor protocol
• Custom certificate of analysis (CoA) covering ICH Q3A/B impurity thresholds
• ISO 9001:2015 for process documentation and traceability

Typical usage ratio

• Dependent on the formulated drug’s investigational design; trial-scale lots range from 0.2–100 g per batch, with API ratios from 0.5–70% in custom preclinical mixtures

Downstream process integration

• Sotalol is introduced during preformulation, micronization, and early phase stability evaluation, supporting pilot-scale and small-scale clinical manufacturing

Final product types

• Clinical trial pharmaceutical samples (tablets, solutions, suspensions)
• Pediatric dispersible mini-tablets

4. Reference Standard Producers: Analytical and Quality Control Markets

Producers of certified reference standards and analytical laboratories procure Sotalol for creating traceable calibrants used in pharmaceutical QC, pharmacokinetic studies, and regulatory release testing. Material must display absolute purity, well-defined isotopic labeling (if required), and comprehensive QA documentation, enabling precise HPLC, GC, or LC-MS/MS calibration. Our batch records and release specifications support downstream use in the preparation of working standards and system suitability solutions for validated analytical methods across global testing labs.

Industry compliance standards

• ISO/IEC 17025 for analytical laboratories
• Requirements of USP/EP Reference Standards program
• ICH Q2(R1) for analytical method validation

Typical usage ratio

• Preparation of calibration solutions typically at 5–500 µg/mL for laboratory use; weighed reference receives solution at 99.5%–100.5% purity in most calibrator blends

Downstream process integration

• Sotalol is dissolved in high-purity solvents by downstream labs to prepare reference solutions, benchmark standards, and quality controls during equipment qualification and batch release testing

Final product types

• Primary and secondary analytical standards
• Certified calibration solutions for regulatory QC